Počet záznamov: 1
Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models
Názov Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models Autor Buociková Verona SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Spoluautori Longhin Eleonora Marta Pilalis Eleftherios Mastrokalou Chara Miklíková Svetlana 1988- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV SCOPUS ORCID Cihová Marína 1984- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Poturnayová Alexandra 1982- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV SCOPUS ORCID Macková Katarína 1990- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV SCOPUS ORCID Bábelová Andrea 1976- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV RID ORCID Trnková Lenka SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Yamani Naouale El Zheng Congying Rios-Mondragon Ivan Labudová Martina 1979 SAVBIOMED ; SAVVIR - Biomedicínske centrum SAV ORCID Csáderová Lucia 1971 SAVBIOMED ; SAVVIR - Biomedicínske centrum SAV ORCID Kuracinová Kristína Makovický Peter SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Kučerová Lucia 1973- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Matúšková Miroslava 1977- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV ORCID Cimpan Mihaela Roxana Dušinská Mária Babál Pavel Chatziioannou Aristotelis Gábelová Alena 1955- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV SCOPUS ORCID Rundén-Pran Elise Smolková Božena 1968- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV SCOPUS RID ORCID Zdroj.dok. Biomedicine & Pharmacotherapy. Vol. 147 (2022), art. no. 112662 Jazyk dok. eng - angličtina Krajina FR - Francúzsko Poznámky open access URL URL link Druh dok. rozpis článkov z periodík (rbx) Ohlasy LI, T.F. - ZHAI, D.Y. - ZHANG, M.M. - YE, R.Y. - KUANG, X.Y. - SHAO, N. - BI, J. - LIN, Y. KIF17 maintains the epithelial phenotype of breast cancer cells and curbs tumour metastasis. In CANCER LETTERS. ISSN 0304-3835, NOV 1 2022, vol. 548. Dostupné na: https://doi.org/10.1016/j.canlet.2022.215904. BALL, H.C. - ALEJO, A.L. - SAMSON, T.K. - ALEJO, A.M. - SAFADI, F.F. Epigenetic Regulation of Chondrocytes and Subchondral Bone in Osteoarthritis. In LIFE-BASEL. APR 2022, vol. 12, no. 4. Dostupné na: https://doi.org/10.3390/life12040582. SRIVASTAVA, R. - LODHI, N. DNA Methylation Malleability and Dysregulation in Cancer Progression: Understanding the Role of PARP1. In BIOMOLECULES. MAR 2022, vol. 12, no. 3. Dostupné na: https://doi.org/10.3390/biom12030417. AYIPO, Yusuf Oloruntoyin - AJIBOYE, Abdulfatai Temitope - OSUNNIRAN, Wahab Adesina - JIMOH, Akeem Adebayo - MORDI, Mohd Nizam. Epigenetic oncogenesis, biomarkers and emerging chemotherapeutics for breast cancer. In Biochimica et Biophysica Acta Gene Regulatory Mechanisms, 2022-10-01, 1865, 7, pp. ISSN 18749399. Dostupné na: https://doi.org/10.1016/j.bbagrm.2022.194873. DUARTE, Diana - VALE, Nuno. Evaluation of synergism in drug combinations and reference models for future orientations in oncology. In Current Research in Pharmacology and Drug Discovery, 2022-01-01, 3, pp. Dostupné na: https://doi.org/10.1016/j.crphar.2022.100110. PENG, B. - ZHANG, S.Y. - CHAN, K.I. - ZHONG, Z.F. - WANG, Y.T. Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer. In MOLECULES. JAN 2023, vol. 28, no. 2. Dostupné na: https://doi.org/10.3390/molecules28020740. APPIAH, C.O. - SINGH, M. - MAY, L. - BAKSHI, I. - VAIDYANATHAN, A. - DENT, P. - GINDER, G. - GRANT, S. - BEAR, H. - LANDRY, J. The epigenetic regulation of cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrence. In EPIGENETIC REGULATION OF CANCER IN RESPONSE TO CHEMOTHERAPY. ISSN 0065-230X, 2023, vol. 158, p. 337-385. Dostupné na: https://doi.org/10.1016/bs.acr.2022.11.001. LI, L.J. - ZHAO, Z.R. - LI, X. Meta -analysis of decitabine pretreatment -based allogeneic hematopoietic stem cell transplantation affecting transplantation -related complications and prognosis in patients with malignant hematological disease. In CELLULAR AND MOLECULAR BIOLOGY. ISSN 0145-5680, 2023, vol. 69, no. 14, p. 69-75. Dostupné na: https://doi.org/10.14715/cmb/2023.69.14.11. SANATI, M. - AFSHARI, A.R. - AHMADI, S.S. - KESHARWANI, P. - SAHEBKAR, A. Aptamers against cancer drug resistance: Small fighters switching tactics in the face of defeat. In BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. ISSN 0925-4439, AUG 2023, vol. 1869, no. 6. Dostupné na: https://doi.org/10.1016/j.bbadis.2023.166720. GAO, T. - SANG, X. - HUANG, X.Y. - GU, P.P. - LIU, J. - LIU, Y.J. - ZHANG, N. Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer. In ACTA PHARMACEUTICA SINICA B. ISSN 2211-3835, OCT 2023, vol. 13, no. 10, p. 4305-4317. Dostupné na: https://doi.org/10.1016/j.apsb.2022.11.018. PIERANTONI, L. - REIS, R.L. - SILVA-CORREIA, J. - OLIVEIRA, J.M. - HEAVEY, S. Spatial -omics technologies: the new enterprise in 3D breast cancer models. In TRENDS IN BIOTECHNOLOGY. ISSN 0167-7799, DEC 2023, vol. 41, no. 12, p. 1488-1500. Dostupné na: https://doi.org/10.1016/j.tibtech.2023.07.003. SANEI, M. - AMIRHEIDARI, B. - SATARZADEH, N. Mutuality of epigenetic and nanoparticles: two sides of a coin. In HELIYON. JAN 15 2024, vol. 10, no. 1. Dostupné na: https://doi.org/10.1016/j.heliyon.2023.e23679. YIN, J. - GU, T.Z. - CHAUDHRY, N. - DAVIDSON, N.E. - HUANG, Y. Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications. In FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, JAN 10 2024, vol. 14. Dostupné na: https://doi.org/10.3389/fimmu.2023.1325615. Kategória ADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných Kategória (od 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Typ výstupu článok Rok vykazovania 2022 Registrované v WOS Registrované v SCOPUS Registrované v CCC DOI 10.1016/j.biopha.2022.112662 
článok
Názov súboru Prístup Veľkosť Stiahnuté Typ Licence Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.pdf Prístupný 8.9 MB 7 Vydavateľská verzia 
CC BY NC ND 4.0rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2022 2021 7.419 Q1 1.194 Q1
Počet záznamov: 1